IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Clinical Psychopharmacology and Neuroscience

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

2.63

h-Index

2022-2023

 37

Rank

2022-2023

 6620

SJR

2022-2023

 0.740

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Clinical Psychopharmacology and Neuroscience
Abbreviation Clin. Psychopharmacol. Neurosci.
Publication Type Journal
Subject Area, Categories, Scope Pharmacology (medical) (Q2); Psychiatry and Mental Health (Q2); Behavioral Neuroscience (Q3)
h-index 37
Overall Rank/Ranking 6620
SCImago Journal Rank (SJR) 0.740
Impact Score 2.63
Publisher Korean College of Neuropsychopharmacology
Country South Korea
ISSN 17381088
Best Quartile Q2
Coverage History 2005-2022




About Clinical Psychopharmacology and Neuroscience


Clinical Psychopharmacology and Neuroscience is a journal covering the technologies/fields/categories related to Pharmacology (medical) (Q2); Psychiatry and Mental Health (Q2); Behavioral Neuroscience (Q3). It is published by Korean College of Neuropsychopharmacology. The overall rank of Clinical Psychopharmacology and Neuroscience is 6620. According to SCImago Journal Rank (SJR), this journal is ranked 0.740. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 37. The best quartile for this journal is Q2.

The ISSN of Clinical Psychopharmacology and Neuroscience journal is 17381088. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Clinical Psychopharmacology and Neuroscience is cited by a total of 598 articles during the last 3 years (Preceding 2022).


Clinical Psychopharmacology and Neuroscience Impact IF 2022-2023


The Impact IF 2022 of Clinical Psychopharmacology and Neuroscience is 2.63, which is computed in 2023 as per its definition. Clinical Psychopharmacology and Neuroscience IF is decreased by a factor of 0.38 and approximate percentage change is -12.62% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Clinical Psychopharmacology and Neuroscience Impact IF 2023 Prediction


Impact IF 2022 of Clinical Psychopharmacology and Neuroscience is 2.63. If the same downward trend persists, Impact IF may fall in 2023 as well.


Impact IF Trend


Year wise Impact IF of Clinical Psychopharmacology and Neuroscience. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 2.63
2021 3.01
2020 2.10
2019 2.09
2018 2.10
2017 2.08
2016 2.00
2015 1.85
2014 2.34

Clinical Psychopharmacology and Neuroscience h-index


  Table Setting

Clinical Psychopharmacology and Neuroscience has an h-index of 37. It means 37 articles of this journal have more than 37 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Clinical Psychopharmacology and Neuroscience ISSN


The ISSN of Clinical Psychopharmacology and Neuroscience is 17381088. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Clinical Psychopharmacology and Neuroscience Rank and SCImago Journal Rank (SJR)


The overall rank of Clinical Psychopharmacology and Neuroscience is 6620. According to SCImago Journal Rank (SJR), this journal is ranked 0.740. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Clinical Psychopharmacology and Neuroscience by Year


Year SJR
2023/2024 Coming Soon
2022 0.740
2021 0.835
2020 0.770
2019 0.748
2018 0.891
2017 0.760
2016 0.893
2015 0.864
2014 0.582

Ranking of Clinical Psychopharmacology and Neuroscience by Year


Year Ranking
2023/2024 Coming Soon
2022 6620
2021 5384
2020 6311
2019 6447
2018 5111
2017 6165
2016 5109
2015 5364
2014 7894

Clinical Psychopharmacology and Neuroscience Publisher


Table Setting

Clinical Psychopharmacology and Neuroscience is published by Korean College of Neuropsychopharmacology. It's publishing house is located in South Korea. Coverage history of this journal is as following: 2005-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Clinical Psychopharmacology and Neuroscience is Clin. Psychopharmacol. Neurosci.. This abbreviation ('Clin. Psychopharmacol. Neurosci.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Clinical Psychopharmacology and Neuroscience


If your research field is/are related to Pharmacology (medical) (Q2); Psychiatry and Mental Health (Q2); Behavioral Neuroscience (Q3), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Clinical Psychopharmacology and Neuroscience?

Clinical Psychopharmacology and Neuroscience latest impact IF is 2.63. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 3.01 (2021) and 1.85 (2015), respectively, in the last 9 years. Moreover, its average IS is 2.24 in the previous 9 years.


What's the SCImago Journal Rank (SJR) of the Clinical Psychopharmacology and Neuroscience?

The Clinical Psychopharmacology and Neuroscience has an SJR (SCImago Journal Rank) of 0.740, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 0.893 in 2016 and the lowest being 0.582 in 2014. Furthermore, the average SJR of the Clinical Psychopharmacology and Neuroscience over the previous 9-year period stands at 2.24.


What's the latest h-index of the Clinical Psychopharmacology and Neuroscience?

The latest h-index of the Clinical Psychopharmacology and Neuroscience is 37.


Who's the publisher of the Clinical Psychopharmacology and Neuroscience?

The Clinical Psychopharmacology and Neuroscience is published by the Korean College of Neuropsychopharmacology, with its country of publication being the South Korea.


What's the current ranking of the Clinical Psychopharmacology and Neuroscience?

The Clinical Psychopharmacology and Neuroscience is currently ranked 6620 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 5109 in 2016 and its lowest position of 7894 in 2014.


What's the abbreviation or short name for the Clinical Psychopharmacology and Neuroscience?

The standard ISO4 abbreviation for the Clinical Psychopharmacology and Neuroscience is Clin. Psychopharmacol. Neurosci..


Is the "Clinical Psychopharmacology and Neuroscience" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Clinical Psychopharmacology and Neuroscience is classified as a journal that the Korean College of Neuropsychopharmacology publishes.


What's the scope or major areas of the Clinical Psychopharmacology and Neuroscience?

The Clinical Psychopharmacology and Neuroscience encompasses the following areas:

  • Pharmacology (medical)
  • Psychiatry and Mental Health
  • Behavioral Neuroscience

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Clinical Psychopharmacology and Neuroscience?

The Clinical Psychopharmacology and Neuroscience is assigned the following International Standard Serial Numbers (ISSN): 17381088.


What's the best quartile of the Clinical Psychopharmacology and Neuroscience?

The best quartile for the Clinical Psychopharmacology and Neuroscience is Q2 (2022).


What's the coverage history of the Clinical Psychopharmacology and Neuroscience?

The Clinical Psychopharmacology and Neuroscience coverage history can be summarized as follows: 2005-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Revue Francophone des Laboratoires (discontinued) journal 23244 Elsevier Masson s.r.l. 8 0.00
Archives of Phytopathology and Plant Protection journal 14852 Taylor and Francis Ltd. 29 1.14
Air and Space Power Journal (discontinued) journal 28397 AU Press 9 0.20
British Journal of Special Education journal 12024 Wiley-Blackwell Publishing Ltd 42 1.24
Howard Journal of Communications journal 9564 Taylor and Francis Ltd. 36 1.66
Proceedings of the International Semiconductor Conference, CAS conference and proceedings 25734 Institute of Electrical and Electronics Engineers Inc. 16 0.00
Proteomics - Clinical Applications journal 9140 Wiley-VCH Verlag 59 2.02
Archiv fur Geflugelkunde journal 28770 Verlag Eugen Ulmer 30 0.00
European Journal of Cancer, Supplement journal 9063 Elsevier Ltd. 28 1.93
Geo-Info journal 30490 Nederlandse Vereniging voor Kartografie 2 0.00

Check complete list




Year wise Impact Score (IS) of Clinical Psychopharmacology and Neuroscience

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 2.63
2021 3.01
2020 2.10
2019 2.09
2018 2.10
2017 2.08
2016 2.00
2015 1.85
2014 2.34



Top Journals/Conferences in Pharmacology (medical)

Drug Resistance Updates
Churchill Livingstone | United States

npj Vaccines
Nature Publishing Group | United Kingdom

Pharmacology and Therapeutics
Elsevier Inc. | United States

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

American Journal of Transplantation
Wiley-Blackwell Publishing Ltd | United Kingdom

Journal of Biomedical Science
BioMed Central Ltd. | United Kingdom

npj Breast Cancer
Nature Publishing Group | United Kingdom

Drugs
Adis International Ltd | United Kingdom

Rheumatology
Oxford University Press | United Kingdom

Acta Pharmacologica Sinica
Nature Publishing Group | United Kingdom

See All

Top Journals/Conferences in Psychiatry and Mental Health

World Psychiatry
Wiley-Blackwell | United States

Lancet Psychiatry,The
Elsevier Ltd. | United Kingdom

Annual Review of Clinical Psychology
Annual Reviews Inc. | United States

JAMA Psychiatry
American Medical Association | United States

Evidence-Based Mental Health
BMJ Publishing Group | United Kingdom

Psychotherapy and Psychosomatics
S. Karger AG | Switzerland

Clinical Psychology Review
Elsevier Inc. | United States

American Journal of Psychiatry
American Psychiatric Association | United States

Journal of the American Academy of Child and Adolescent Psychiatry
Elsevier Ltd. | United Kingdom

Lancet Healthy Longevity, The
Elsevier Ltd. | United Kingdom

See All

Top Journals/Conferences in Behavioral Neuroscience

Nature Human Behaviour
Nature Publishing Group | United Kingdom

Brain, Behavior, and Immunity
Academic Press Inc. | United States

Neuroscience and Biobehavioral Reviews
Elsevier Ltd. | United Kingdom

Current Opinion in Behavioral Sciences
Elsevier Ltd. | United Kingdom

Current Topics in Behavioral Neurosciences
Springer Verlag | Germany

Journal of Research on Adolescence
Wiley-Blackwell Publishing Ltd | United Kingdom

Journal of Contextual Behavioral Science
Elsevier BV | Netherlands

Journal of Sleep Research
Wiley-Blackwell Publishing Ltd | United Kingdom

Sleep Health
Elsevier Inc. | United States

Translational Behavioral Medicine
Springer Publishing Company | United States

See All